Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,971,980
-
Share change
-
+1,945,739
-
Total reported value
-
$491,287,546
-
Price per share
-
$22.36
-
Number of holders
-
64
-
Value change
-
+$45,614,568
-
Number of buys
-
41
-
Number of sells
-
15
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q4 2018
As of 31 Dec 2018,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,971,980 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Temasek Holdings (Private) Ltd, JPMORGAN CHASE & CO, FMR LLC, RTW INVESTMENTS, LP, BlackRock Inc., Vivo Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Vanguard Group Inc, and Rock Springs Capital Management LP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.